Digital Therapeutics Market Share

North America Market Statistics

North American in digital therapeutics market is set to hold over 40% revenue share by the end of 2036. The landscape's substantial growth in the region is expected to be credited to the surge in chronic illness and neurology devices, coupled with the geriatric population in this region. According to a report by the Centers for Disease Control and Prevention 2020, more than 51.8% of US adults suffer from one chronic condition, and more than 27% are predicted to have multiple chronic conditions.

An increasing augment in healthcare spending in the United States would be a key growth driver for this market value. According to the American Medical Association 2024, U.S. health spending increased by 4% in 2022.

Government of Canada stated that in 2020, about 1 in 3 Canadians in their lifetime will be affected by mental illness. Moreover, it is expected that about 21% of Canadians which is more than 6 million people, who in their lifetime are estimated to meet the criteria for addiction.

Asia Pacific Market Analysis

The Asia Pacific region will also encounter a huge influence on the digital therapeutics market demand during the forecast period and will account for the second position attributed to the increasing aging population. According to the Census 2022, the older population in APAC is expected to be about 20% higher than the total population of the U.S. population.

In China, the growing demand for better medical devices in this region is slated to increase. According to a report in 2024, China’s medical device industry makes up an average of about 20–30% of its international revenue.

There has been an increase in healthcare expenditures in Japan which will increase the market size expansion of the home healthcare sector. According to a report by the National Institutes of Health 2020, on average Japan's average medical expenditure is about USD 3273 per person.